According to a new report from the Tufts Center for the Study of Drug Development at Tufts University 12 to 50 percent of the drugs companies are developing, depending on the company, involved a personalized medicine approach. The Tufts report is based on a survey of 25 companies, large and small, to which 16 companies [...]
Filed under: clinical research, Clinical Trial, drug development, drug discoverry, personalized medicine, Pharmacogenomics, Theranostics | Tagged: Drug Development, drug discovery, personalized medicine, theranostics | Leave a Comment »











